MT1-MMP inactivates ADAM9 to regulate FGFR2 signaling and calvarial osteogenesis

Kui Ming Chan1, Hoi Leong Xavier Wong, Guoxiang Jin

  • 1Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen, China.

Developmental Cell
|May 29, 2012
PubMed

Insights

Matrix metalloproteinase-14 (MT1-MMP) protects FGFR2 signaling in osteoblasts by inactivating ADAM9. This maintains calvarial bone growth, and its absence causes craniofacial abnormalities.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Biochemistry

Background:

  • Matrix metalloproteinase-14 (MT1-MMP) is crucial for extracellular matrix remodeling and cell surface receptor modulation.
  • Loss of MT1-MMP function leads to craniofacial abnormalities, indicating its importance in skeletal development.

Purpose of the Study:

  • To elucidate the mechanism by which MT1-MMP regulates FGFR2 signaling in osteoblasts.
  • To investigate the role of MT1-MMP in calvarial bone development and its interaction with ADAM9 and FGFR2.

Main Methods:

  • Investigated protein interactions between MT1-MMP, ADAM9, and FGFR2 in osteoblasts.
  • Analyzed FGF-induced proliferation and signaling pathways in Mmp14-/- osteoblasts.
  • Assessed calvarial bone growth in Mmp14-/- embryos and the effect of Adam9 depletion.

Main Results:

  • MT1-MMP forms a complex with FGFR2 and ADAM9, proteolytically inactivating ADAM9 and preventing FGFR2 shedding.
  • Mmp14-/- osteoblasts exhibit compromised FGF-induced proliferation and signaling due to ADAM9 upregulation and FGFR2 shedding.
  • MT1-MMP deficiency causes retarded parietal bone growth starting at 15.5 dpc, linked to impaired FGFR2 signaling.
  • Adam9 depletion rescues FGFR2 signaling and restores calvarial bone growth in Mmp14-/- embryos.

Conclusions:

  • MT1-MMP acts as a critical negative regulator of ADAM9 activity, preserving FGFR2 signaling essential for calvarial osteogenesis.
  • This study reveals a novel regulatory mechanism for FGFR2 signaling involving MT1-MMP and ADAM9 in bone development.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...